CoChat

Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients

Wainstein, J., Metzger, M., Boaz, M., Minuchin, O., Cohen, Y., Yaffe, A., Yerushalmy, Y., Raz, I., Harman‐Boehm, I. · 2005 · Diabetic Medicine
Cited by 136

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aims To compare the efficacy of insulin pump treatment with multiple daily injections in the treatment of poorly controlled obese Type 2 diabetic patients already receiving two or more daily injections of insulin plus metformin. Methods Forty obese Type 2 diabetic subjects (using insulin) were randomized to treatment with continuous subcutaneous infusion pump (CSII) (Minimed®) or multiple daily insulin injections (MDI). At the end of the first 18‐week treatment period, patients underwent a 12‐week washout period during which they were treated with MDI plus metformin. They were then crossed‐over to the other treatment for an 18‐week follow‐up period. Patients performed 4‐point daily self blood‐glucose monitoring (SBGM) on a regular basis and 7‐point monitoring prior to visits 2, 8, 10 and 16. A subset of patients underwent continuous glucose monitoring using the Minimed® continuous glucose monitoring system (CGMS) at visits 2, 8, 10 and 16. A standard meal test was performed in which serum glucose was tested at fasting and once each hour for 6 h following a test meal. Glucose levels were plotted against time and the area under the curve (AUC) was calculated. HbA 1c, weight, daily insulin dose and hypoglycaemic episodes were recorded. Results In obese Type 2 diabetic patients already treated with insulin, treatment with CSII significantly reduced HbA 1c levels compared with treatment with MDI. An additional CSII treatment benefit was demonstrated by reduced meal‐test glucose AUC. Initial reduction of daily insulin requirement observed in CSII‐treated subjects during the first treatment period was attributable to a period effect and did not persist over time. Conclusions In the intent‐to‐treat analysis, CSII appeared to be superior to MDI in reducing HbA 1c and glucose AUC values without significant change in weight or insulin dose in obese, uncontrolled, insulin‐treated Type 2 diabetic subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2005.01597.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 136

Metadata

Authors
Wainstein, J., Metzger, M., Boaz, M., Minuchin, O., Cohen, Y., Yaffe, A., Yerushalmy, Y., Raz, I., & Harman‐Boehm, I.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2005-07-13
Volume
22
Issue
8
Pages
1037-1046
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1965722550
Cited by
136
References
3
FWCI
4.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. https://app.cochat.ai/papers/10.1111/j.1464-5491.2005.01597.x
The paper
Wainstein, J., Metzger, M., Boaz, M., Minuchin, O., Cohen, Y., Yaffe, A., Yerushalmy, Y., Raz, I., & Harman‐Boehm, I. (2005). Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2005.01597.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.